These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
729 related articles for article (PubMed ID: 22786682)
1. PGC-1α rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Tsunemi T; Ashe TD; Morrison BE; Soriano KR; Au J; Roque RA; Lazarowski ER; Damian VA; Masliah E; La Spada AR Sci Transl Med; 2012 Jul; 4(142):142ra97. PubMed ID: 22786682 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease. Jin J; Albertz J; Guo Z; Peng Q; Rudow G; Troncoso JC; Ross CA; Duan W J Neurochem; 2013 May; 125(3):410-9. PubMed ID: 23373812 [TBL] [Abstract][Full Text] [Related]
3. PPARGC1A/PGC-1α, TFEB and enhanced proteostasis in Huntington disease: defining regulatory linkages between energy production and protein-organelle quality control. La Spada AR Autophagy; 2012 Dec; 8(12):1845-7. PubMed ID: 22932698 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cui L; Jeong H; Borovecki F; Parkhurst CN; Tanese N; Krainc D Cell; 2006 Oct; 127(1):59-69. PubMed ID: 17018277 [TBL] [Abstract][Full Text] [Related]
5. Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease. Hathorn T; Snyder-Keller A; Messer A Neurobiol Dis; 2011 Jan; 41(1):43-50. PubMed ID: 20736066 [TBL] [Abstract][Full Text] [Related]
6. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Weydt P; Pineda VV; Torrence AE; Libby RT; Satterfield TF; Lazarowski ER; Gilbert ML; Morton GJ; Bammler TK; Strand AD; Cui L; Beyer RP; Easley CN; Smith AC; Krainc D; Luquet S; Sweet IR; Schwartz MW; La Spada AR Cell Metab; 2006 Nov; 4(5):349-62. PubMed ID: 17055784 [TBL] [Abstract][Full Text] [Related]
7. Exercise induces TFEB expression and activity in skeletal muscle in a PGC-1α-dependent manner. Erlich AT; Brownlee DM; Beyfuss K; Hood DA Am J Physiol Cell Physiol; 2018 Jan; 314(1):C62-C72. PubMed ID: 29046293 [TBL] [Abstract][Full Text] [Related]
9. Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease. Chaturvedi RK; Hennessey T; Johri A; Tiwari SK; Mishra D; Agarwal S; Kim YS; Beal MF Hum Mol Genet; 2012 Aug; 21(15):3474-88. PubMed ID: 22589249 [TBL] [Abstract][Full Text] [Related]
10. The dysfunction of hepatic transcriptional factors in mice with Huntington's Disease. Chiang MC; Chern Y; Juo CG Biochim Biophys Acta; 2011 Sep; 1812(9):1111-20. PubMed ID: 21651979 [TBL] [Abstract][Full Text] [Related]
11. Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation. Chaturvedi RK; Calingasan NY; Yang L; Hennessey T; Johri A; Beal MF Hum Mol Genet; 2010 Aug; 19(16):3190-205. PubMed ID: 20529956 [TBL] [Abstract][Full Text] [Related]
12. PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease. Chiang MC; Chern Y; Huang RN Neurobiol Dis; 2012 Jan; 45(1):322-8. PubMed ID: 21907283 [TBL] [Abstract][Full Text] [Related]
13. Regulation of PGC-1α expression by a GSK-3β-TFEB signaling axis in skeletal muscle. Theeuwes WF; Gosker HR; Schols AMWJ; Langen RCJ; Remels AHV Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118610. PubMed ID: 31738957 [TBL] [Abstract][Full Text] [Related]
14. Autophagy Activation by Transcription Factor EB (TFEB) in Striatum of HDQ175/Q7 Mice. Vodicka P; Chase K; Iuliano M; Tousley A; Valentine DT; Sapp E; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M J Huntingtons Dis; 2016 Oct; 5(3):249-260. PubMed ID: 27689619 [TBL] [Abstract][Full Text] [Related]
15. Activating mitochondrial regulator PGC-1α expression by astrocytic NGF is a therapeutic strategy for Huntington's disease. Chen LW; Horng LY; Wu CL; Sung HC; Wu RT Neuropharmacology; 2012 Sep; 63(4):719-32. PubMed ID: 22633948 [TBL] [Abstract][Full Text] [Related]
16. PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond. Tsunemi T; La Spada AR Prog Neurobiol; 2012 May; 97(2):142-51. PubMed ID: 22100502 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease. Johri A; Calingasan NY; Hennessey TM; Sharma A; Yang L; Wille E; Chandra A; Beal MF Hum Mol Genet; 2012 Mar; 21(5):1124-37. PubMed ID: 22095692 [TBL] [Abstract][Full Text] [Related]
18. PGC-1alpha, a new therapeutic target in Huntington's disease? McGill JK; Beal MF Cell; 2006 Nov; 127(3):465-8. PubMed ID: 17081970 [TBL] [Abstract][Full Text] [Related]
19. Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter. Martin E; Betuing S; Pagès C; Cambon K; Auregan G; Deglon N; Roze E; Caboche J Hum Mol Genet; 2011 Jun; 20(12):2422-34. PubMed ID: 21493629 [TBL] [Abstract][Full Text] [Related]
20. Transcription factor EB modulates the homeostasis of reactive oxygen species in intestinal epithelial cells to alleviate inflammatory bowel disease. Zhang T; Zhang R; Liu W; Qi Y; Wang H; Zhang H; Xiao Z; Pandol SJ; Han YP; Zheng X Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167065. PubMed ID: 38342419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]